Vext Science (TSE:VEXT) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vext Science, Inc. reported its financial results for Q4 and the full year of 2023, showcasing a revenue of $34.8 million and an EBITDA of $16.6 million, with significant growth anticipated from the launch of an adult-use program in Ohio. The company is well-positioned with a vertically-integrated operation in Ohio, expecting to capture a considerable market share as Ohio’s cannabis market is projected to reach $4 billion by 2028. Vext’s strategic initiatives in Arizona and expansion in Ohio are set to enhance long-term profitability and cash flow.
For further insights into TSE:VEXT stock, check out TipRanks’ Stock Analysis page.